Samurai 8 wasn't a declining franchise, it was a failed franchise. There's a big difference between something that was popular but dropped off a bit and something that was never popular from the beginning.
Also everything sold a lot better back in Gintama's day, series selling 100k per volume could get cancelled early on since everything else did better than that. Gintama was top of the mid-tier back in it's peak, just like Black Clover is now. Black Clover's not going to end in under 2 years, especially with an anime that's not ending until next year at the earliest (due to the break and number of episodes we know are already planned).
Toriko and Beelzebub continued for 2 years at the bottom after their anime ended and that was in a significantly more competitive line-up than current WSJ which will soon be more than half filled with series less than a year old (plus Beel's anime wasn't even very popular).
You can convince yourself it's an unpopular flop all you want but it's not going away any time soon.
I didn't state at any point that BC was an "unpopular flop" but nice attempt in trying to paint a false narrative, I guess.
I said it was a moderately successful anime and average seller as a manga. Both statements are accurate. Please prove these statements wrong otherwise
Are we really going back to this argument "Everything sold better back then".
It's funny how the top series in WSJ right now, One Piece, KNY, MHA, TPN, HQ are all selling similarly to back then.
JK (without an anime) outsells BC (with an anime). Meaning with an anime, it can at the very least do 400-500k.
World Trigger continued to grow AFTER it's hiatus and reached new peaks.
Dr. Stone is on the rise and almost matches BC meaning its franchise is growing.
SxF a brand new series exploded with popularity right off the bat with more sales.
Act Age and CSM, both very non-conventional WSJ series are growing with very single volume. Act Age is slowly catching up to BC as well.
But sure, when it comes to your series, "Everything sold better back then".
It's such a lazy argument.
RxL, S8, Illegal Rare all had decent numbers for a starting franchise but the lack of growth meant it wasn't worth the investment. BC's growth is not +ve, it's -ve. Meaning there is no growth for BC.
The comparison is because they fill about the same spot in the magazine from their respective eras, Gintama was pretty much the top of the mid-tier series but couldn't compete with the top pillars of the magazine, which is the same state as Black Clover.
This is an era of Jump where series (that aren't gag manga) sell under 100k per volume last more than 200 chapters and end naturally. And some series popular enough to be at the top of the magazine are selling the amount some mid-magazine stuff did in the 00s.
And now that they've got 8 slots filled by new at-risk series (likely 9 soon), standards for success are probably just going to drop even more.
Gintama was a top-tier series. It wasn't mid-tier. It was top tier because what it did as a comedy was akin to what Naruto/Bleach, at the very least, did as a battle manga.
Gintama's peak print numbers were 700k, if I'm not mistaken. It sold more than any other comedy in WSJ. It's anime grossed more (both as movies and in sales) than any other long running franchise. It's franchise revenue for multiple years was among the top. Yeah, sure. BC and Gintama are totally the same tiers.
Thanks for the laugh, I guess.
Like I said, BC is fine for now. WSJ also needs new series to pick up.
But I'd still wager, 1.5 years with declining sales will definitely lead to it's end.
If you've been following WSJ properly, you'd know this by now.